Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Muscle Nerve ; 49(1): 134-8, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23893323

ABSTRACT

INTRODUCTION: Erythromelalgia due to heterozygous gain-of-function SCN9A mutations usually presents as a pure sensory-autonomic disorder characterized by recurrent episodes of burning pain and redness of the extremities. METHODS: We describe a patient with an unusual phenotypic presentation of gross motor delay, childhood-onset erythromelalgia, extreme visceral pain episodes, hypesthesia, and self-mutilation. The investigation of the patient's motor delay included various biochemical analyses, a comparative genomic hybridization array (CGH), electromyogram (EMG), and muscle biopsy. Once erythromelalgia was suspected clinically, the SCN9A gene was sequenced. RESULTS: The EMG, CGH, and biochemical tests were negative. The biopsy showed an axonal neuropathy and neurogenic atrophy. Sequencing of SCN9A revealed a heterozygous missense mutation in exon 7; p.I234T. CONCLUSIONS: This is a case of global motor delay and erythromelalgia associated with SCN9A. The motor delay may be attributed to the extreme pain episodes or to a developmental perturbation of proprioceptive inputs.


Subject(s)
Motor Skills Disorders/genetics , Mutation, Missense/genetics , NAV1.7 Voltage-Gated Sodium Channel/genetics , Severity of Illness Index , Somatoform Disorders/genetics , Carbamazepine/therapeutic use , Child, Preschool , Comorbidity , Erythromelalgia/drug therapy , Erythromelalgia/epidemiology , Erythromelalgia/genetics , Female , Humans , Hypesthesia/drug therapy , Hypesthesia/epidemiology , Hypesthesia/genetics , Mexiletine/therapeutic use , Motor Skills Disorders/drug therapy , Motor Skills Disorders/epidemiology , Somatoform Disorders/drug therapy , Somatoform Disorders/epidemiology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...